Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)

Clinical trial NCT00446134 · COMPLETED

Trial details

NCT number: NCT00446134
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2007-03-01
Primary completion: 2008-04-01
Enrollment: 278

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.